(Q39689280)

English

A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients

scientific article published on September 2004

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

14 September 2017

A 6-month randomized clinical trial of bimatoprost 0.03% versus the association of timolol 0.5% and latanoprost 0.005% in glaucomatous patients (English)

1 reference

Europe PubMed Central

14 September 2017

1 reference

based on heuristic

inferred from title

author name string

Gianluca Manni

1

1 reference

Europe PubMed Central

14 September 2017

Marco Centofanti

2

1 reference

Europe PubMed Central

14 September 2017

Mariacristina Parravano

3

1 reference

Europe PubMed Central

14 September 2017

Francesco Oddone

4

1 reference

Europe PubMed Central

14 September 2017

Massimo G Bucci

5

1 reference

Europe PubMed Central

14 September 2017

publication date

1 September 2004

1 reference

Europe PubMed Central

14 September 2017

Graefe's Archive for Clinical and Experimental Ophthalmology

1 reference

Europe PubMed Central

14 September 2017

242

1 reference

Europe PubMed Central

14 September 2017

9

1 reference

Europe PubMed Central

14 September 2017

767-770

1 reference

Europe PubMed Central

14 September 2017

https://scigraph.springernature.com/pub.10.1007/s00417-004-0866-2

0 references

Additive IOP-reducing effect of latanoprost in patients insufficiently controlled on timolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Collaborative Normal-Tension Glaucoma Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Efficacy and tolerability of timolol maleate ophthalmic gel-forming solution versus timolol ophthalmic solution in adults with open-angle glaucoma or ocular hypertension: a six-month, double-masked, multicenter study

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic adverse effects of beta-adrenergic blockers: an evidence-based assessment

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effects of AGN 192024, a new ocular hypotensive agent, on aqueous dynamics

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Six-month comparison of bimatoprost once-daily and twice-daily with timolol twice-daily in patients with elevated intraocular pressure

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term drift and timolol therapy: possible role for pulsed therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

One-year, randomized study comparing bimatoprost and timolol in glaucoma and ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Three-month comparison of bimatoprost and latanoprost in patients with glaucoma and ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The pharmacology of bimatoprost (Lumigan).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of once- or twice-daily bimatoprost with twice-daily timolol in patients with elevated IOP : a 3-month clinical trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mechanism of action of bimatoprost (Lumigan).

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bimatoprost vs. timolol

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Bimatoprost and its free acid are prostaglandin FP receptor agonists

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of the ocular hypotensive lipid AGN 192024 with timolol: dosing, efficacy, and safety evaluation of a novel compound for glaucoma management

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A six-month randomized clinical trial comparing the intraocular pressure-lowering efficacy of bimatoprost and latanoprost in patients with ocular hypertension or glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration.The AGIS Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive intraocular pressure lowering effect of various medications with latanoprost

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prevalence of ocular symptoms and signs with preserved and preservative free glaucoma medication.

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Quantitative analysis of eyelash lengthening following topical latanoprost therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Meta-analysis of randomised controlled trials comparing latanoprost with timolol in the treatment of patients with open angle glaucoma or ocular hypertension

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Changing paradigms in the medical treatment of glaucoma

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Expectations from clinical trials: results of the Early Manifest Glaucoma Trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/15241611

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00417-004-0866-2

1 reference

Europe PubMed Central

14 September 2017

1 reference

Europe PubMed Central

14 September 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q39689280&oldid=1856440080"